One of the main driving forces of hemodiafiltration relies on the higher total dialytic dose delivered that includes total ultrafiltration volume, namely the convective dose, that increase and extend molecular weight spectrum of uremic compounds…

This presentation starts with an introduction about high-volume HDF including the main reasons behind the use and application of high-volume HDF. Furthermore, factors that influence convection volumes and the application of high-volume HDF will be…

High-volume hemodiafiltration (HDF) and conventional hemodialysis have been compared in several clinical studies, including a number of large randomized controlled trials. This presentation will guide you through the clinical studies and explain the evidence available…

Despite the need to improve survival rates of dialysis patients and the acknowledged survival benefit that HDF offers, there is limited utilization of HDF in some countries. In this presentation, a value-based case for HDF…

As the clinical experience with HDF accumulates globally, it is worth examining the evidence for this kidney replacement therapy as used in routine clinical care. Such real-world evidence is increasingly recognized as valuable by clinicians…

In this webinar environmental issues and measures of chronic hemodialysis therapy will be addressed. Hemodialysis saves lives but consumes large amounts of water and power and produces a lot of care-related waste. It must be…

The available evidence on the beneficial effects of HDF raise the question regarding the possible mechanisms of the observed effects on improved survival reported for HDF. Factors, as the effects on the removal of middle…

This roundtable webinar will introduce hemodiafiltration and examine whether it should become the gold standard for dialysis in the United States. To help address this question, the results of the CONVINCE Trial in the context…

In this webinar, we will shed light on the growing evidence of the beneficial effect of high-volume hemodiafiltration on health-related quality of life of patients with end-stage kidney failure: how it can be measured, who…

As the clinical experience with HDF accumulates globally, it is worth examining the evidence for this kidney replacement therapy as used in routine clinical care. Clinicians increasingly recognize Such real-world evidence as valuable and may…

One of the main driving forces of hemodiafiltration relies on the higher total dialytic dose delivered that includes total ultrafiltration volume, namely the convective dose, that increase and extend molecular weight spectrum of uremic compounds…

In this webinar environmental issues and measures of chronic hemodialysis therapy will be addressed. Hemodialysis saves lives but consumes large amounts of water and power and produces a lot of care-related waste. It must be…

Interview at ERA 2023: CONVINCE Event Date: 8/2023

The available evidence on the beneficial effects of HDF raises the question regarding the possible mechanisms of the observed effects on improved survival reported for HDF. Factors, such as the effects on the removal of…

In this webinar you will be introduced to the topic of water quality and dialysis fluids quality in chronic hemodialysis, including hemodiafiltration. We will address the importance of water and dialysis fluids quality, its impact…

The aim of this recent individual patient data meta-analysis is to present an overview of the existing evidence from randomised controlled trials comparing haemodiafiltration versus haemodialysis that were designed to assess all-cause mortality in patients…